Evidence map›Paper›PMID 41229907›Full record

ArticleDiscover public health2025

Understanding medical students' knowledge, attitudes, and preparatory needs for future prescribing of long-acting injectable pre-exposure prophylaxis.

Kenneth Cole, Jacob Bleasdale, Amy Hequembourg, Gene Morse, Sarahmona Przybyla

Abstract read
In one paragraph

Article in Discover public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kenneth ColeUniversity at Buffalo, Buffalo, NY USA.
Jacob BleasdaleUniversity of Central Florida, Orlando, FL USA.
Amy HequembourgUniversity at Buffalo, Buffalo, NY USA.
Gene MorseUniversity at Buffalo, Buffalo, NY USA.
Sarahmona PrzybylaUniversity at Buffalo, Buffalo, NY USA.

Funding

University of Buffalo Clinical and Translational Science Institute - Supplement SchulyerUL1TR001412 · NCATS · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI MURPHY, TIMOTHY F · 2015 to 2024
$33.8M
Translational Science Training to Reduce the Impact of Alcohol on HIV InfectionT32AA025877 · NIAAA · UNIVERSITY OF FLORIDA · PI Robert L Cook, DEBRA E LYON · 2018 to 2026
$3.3M
NCATS NIH HHS UL1 TR001412NIAAA NIH HHS T32 AA025877
6 · The paper itself

Abstract

Injectable pre-exposure prophylaxis (PrEP) offers a novel approach to Human Immunodeficiency Virus (HIV) prevention and may increase accessibility for people vulnerable to HIV acquisition. However, effective implementation will require that healthcare providers are aware and knowledgeable of injectable PrEP. One avenue to increasing awareness and knowledge among healthcare providers is to educate future providers during their medical education. From June to August 2022, we conducted in-depth, semi-structured interviews with medical students (

Indexed as

HIVInjectable PrEPMedical studentsPre-exposure prophylaxis (PrEP)

Identifiers

PMID41229907
PMCPMC12602550

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.